The Effect and Mechanisms of the Second-meal Phenomenon in Type 2 Diabetic Patients

This study has been completed.
Sponsor:
Information provided by:
The Catholic University of Korea
ClinicalTrials.gov Identifier:
NCT01127997
First received: May 20, 2010
Last updated: August 20, 2010
Last verified: May 2010
  Purpose

Second-meal phenomenon denotes the effect of a prior meal in decreasing the rise in blood glucose after a subsequent meal. This phenomenon occurs in normal subjects while it is not clear whether it is also observed in type 2 diabetic patients. This study aims to define whether the second-meal phenomenon occurs in type 2 diabetic patients. We will also seek for the mechanism.


Condition
Type 2 Diabetes

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: The Effect and Mechanisms of the Second-meal Phenomenon in Type 2 Diabetic

Resource links provided by NLM:


Further study details as provided by The Catholic University of Korea:

Primary Outcome Measures:
  • Area under the curve of plasma glucose after meal [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Compare the post-lunch AUC of glucose between two meal tolerance tests(one after having breakfast, one after not having breakfast)


Secondary Outcome Measures:
  • the mechanism of second-meal phenomenon [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    serum FFA, plasma insulin, C-peptide, incretin concentration will be measured


Biospecimen Retention:   Samples Without DNA

plasma, serum


Estimated Enrollment: 12
Study Start Date: March 2010
Study Completion Date: August 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
study A
post-breakfast meal tolerance test + post-lunch meal tolerance test
study B
fasting + post-lunch meal tolerance test

  Eligibility

Ages Eligible for Study:   35 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

type 2 diabetic patients

Criteria

Inclusion Criteria:

  • age 35-70
  • HbA1c 6-8%
  • DM duration less than 5 yrs

Exclusion Criteria:

  • type 1 DM, secondary DM, gestational DM
  • patients using insulin, TZDs
  • patients using corticosteroid, herb medication or other medications affecting glucose tolerance
  • renal dysfunction (Cr > 1.5mg/dL)
  • hepatic dysfunction (LFT > x 3UNL)
  • anemia (Hg < 10g/dL)
  • ischemic heart disease, congestive heart failure
  • severe diabetic complication (CRF, CVA, PDR, gastroparesis)
  • infectious disease
  • malignancy
  • pregnant women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01127997

Locations
Korea, Republic of
St. Vincent's hospital
Suwon, Kyounggi-do, Korea, Republic of, 442-723
Sponsors and Collaborators
The Catholic University of Korea
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Seung-Hwan Lee, The Catholic University of Korea
ClinicalTrials.gov Identifier: NCT01127997     History of Changes
Other Study ID Numbers: VC10EISI0007
Study First Received: May 20, 2010
Last Updated: August 20, 2010
Health Authority: Korea: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on July 26, 2014